CTLA4 and cancer: The IS score is known to be a transcriptional predictor of anti-CTLA-4 immune checkpoint inhibitor and was assessed in the genomic data from ~10,000 human tissues across 30 different cancer types to estimate the potential response to immunotherapy35.